CTI BioPharma

YTD

ALL

Why Robinhood?

You can watch CTI BioPharma and buy or sell other stocks, ETFs, and their options commission-free!

About CTIC

CTI BioPharma Corp. engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.

CEO

Adam R. Craig, MD, PhD

CEOAdam R. Craig, MD, PhD

Employees

—

Employees—

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

1991

Founded1991

Employees

—

Employees—

CTIC Key Statistics

Market cap

1.20B

Market cap1.20B

Price-Earnings ratio

-15.78

Price-Earnings ratio-15.78

Dividend yield

—

Dividend yield—

Average volume

4.57M

Average volume4.57M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.10

52 Week high$9.10

52 Week low

$4.01

52 Week low$4.01

People also own

Based on the portfolios of people who own CTIC. This list is generated using Robinhood data, and it’s not a recommendation.

Cenntro Electric Group Li…